SCHEMBL14948252

SCHEMBL14948252

COC(=N)Cc1ccc(Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.49
KDM4E B2RXH2 1/20 0.49
GLA P06280 1/20 0.49
ALDH1A1 P00352 3/20 0.43
IDO1 P14902 2/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
HTT P42858 1/20 0.42
EGFR P00533 1/20 0.42
ERBB2 P04626 1/20 0.42
LMNA P02545 2/20 0.41
HPGD P15428 1/20 0.41
CASP3 P42574 1/20 0.41
ATM Q13315 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41
TAAR1 Q96RJ0 1/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14935731 0.98 L3MBTL1 (0.47) L3MBTL1KDM4EGLAALDH1A1IDO1
SCHEMBL18324623 0.81 CA2 (0.45) ALDH1A1IDO1HTTLMNA
SCHEMBL20278237 0.81 IDO1 (0.44) L3MBTL1ALDH1A1IDO1KMT2AMEN1
SCHEMBL24574882 0.80 KMT2A (0.45) L3MBTL1KDM4EGLAIDO1KMT2A
SCHEMBL1751119 0.79 KMT2A (0.45) KDM4EIDO1KMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL15663073 0.79 CA2 (0.43) ALDH1A1IDO1KMT2AHTTLMNA
SCHEMBL11197630 0.78 ALDH1A1 (0.44) L3MBTL1KDM4EALDH1A1KMT2AMEN1
Hydrochloric Acid SCHEMBL6870271 0.78 IDO1 (0.41) ALDH1A1IDO1KMT2AMEN1SMN1; SMN2
Hydrochloric Acid SCHEMBL4737475 0.77 ALDH1A1 (0.43) L3MBTL1KDM4EALDH1A1IDO1KMT2A
Hydrochloric Acid SCHEMBL6867291 0.76 KMT2A (0.43) KDM4EIDO1KMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9433631-B2 4-pregenen-11β-17-21-triol-3,20-dione derivatives ALLERGAN, INC. (US) 2016-09-06 US disclosed
US-20150057258-A1 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES ALLERGAN, INC. 2015-02-26 US disclosed
US-8906892-B2 4-pregenen-11β-17-21-triol-3,20-dione derivatives ALLERGAN, INC. (US) 2014-12-09 US disclosed
WO-2013071009-A1 4 - PREGENEN- 11SS - 17 - 21 -TRIOL-3, 20 -DIONE DERIVATIVES FOR THE TREATMENT OF OCULAR CONDITIONS ALLERGAN, INC. (US) 2013-05-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150057258-A1 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES NR3C2, HSD3B1, HSD3B2 L3MBTL1 4871/4885KDM4E 3046/4885GLA 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.